menu

Medical Industry Feature: What the PsA LOOP Study Means for Dermatologists & Rheumatologists

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

What the PsA LOOP Study Means for Dermatologists & Rheumatologists

Program Information
Recommended
What the PsA LOOP Study Means for Dermatologists & Rheumatologists
RestartResume
About 30% of psoriasis patients will go on to develop PsA. What part does your clinical specialty play in getting those patients to treatment faster?
  • Sponsored by

  • Overview

    When left untreated, psoriatic arthritis (PsA) can lead to joint damage, disability, and other severe symptoms that significantly reduce a patient’s quality of life. That’s why rheumatologist Dr. Phil Mease and dermatologist Dr. Clive Liu discuss the LOOP observational study, which assessed the role of these two clinical specialties in the diagnosis and treatment of patients with PsA.

    This activity is intended for United States and Puerto Rico health care professionals only and was developed by AbbVie.

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 7/18/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.